ClinicalTrials.Veeva

Find clinical trials for Lung Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near London, England, GBR:

Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)

Probe Breath Biopsy Test to differentiate between individuals with lung cancer and relevant contrast groups.The contrast groups wil...

Enrolling
Lung Cancer
Diagnostic Test: OWL-EVO1

Phase 2

Owlstone Medical

London, United Kingdom and 8 other locations

stereotactic body radiotherapy (SBRT) for early stage non-small cell lung cancer.SBRT will be delivered in either 3 or 5 fractions ...

Active, not recruiting
Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage I
Radiation: Stereotactic body radiotherapy
Drug: Nivolumab

Phase 1, Phase 2

Royal Marsden NHS Foundation Trust

Sutton, United Kingdom

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a
Drug: Docetaxel

Phase 3

Daiichi Sankyo

London, United Kingdom and 205 other locations

The trial consists of a series of parallel multi-centre single arm phase II trial arms, each testing an experimental targeted drug in a population st...

Active, not recruiting
Non-Small Cell Lung Cancer
Carcinoma, Squamous Cell
Drug: AZD5363
Drug: Selumetinib

Phase 2

University of Birmingham

London, United Kingdom and 24 other locations

This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...

Active, not recruiting
Non-Small Cell Lung Cancer Metastatic
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Drug: Patritumab Deruxtecan (Fixed dose)
Drug: Patritumab Deruxtecan (Up-Titration)

Phase 2

Daiichi Sankyo

London, United Kingdom and 122 other locations

The main aim of this study is to:evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1] by investiga...

Active, not recruiting
Relapsed/Refractory Small Cell Lung Cancer
Drug: Tarlatamab

Phase 2

Amgen
Amgen

London, United Kingdom and 79 other locations

Locations recently updated

docetaxel in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and unresectable NSCLC after chemoradiothera...

Enrolling
Non-Small Cell Lung Cancer
Drug: Paclitaxel
Drug: Docetaxel

Phase 1

BioNTech
BioNTech

London, United Kingdom and 33 other locations

The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...

Enrolling
Resectable Non-Small-Cell Lung Cancer
Lung Cancer
Drug: Nab-paclitaxel
Drug: Etrumadenant (ETRUMA)

Phase 2

Gilead Sciences
Gilead Sciences

London, United Kingdom and 59 other locations

A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: MEDI4736

Phase 2

AstraZeneca
AstraZeneca

London, United Kingdom and 137 other locations

overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...

Active, not recruiting
Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Paclitaxel

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

London, Greater London, United Kingdom and 126 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems